Investor Relations Home

2014 Annual Report
2014 Annual Report
2012 Annual Report
2012 Annual Report
2011 Annual Report
2011 Annual Report
2009 Annual Report
2009 Annual Report
2008 Annual Report
2008 Annual Report
2007 Annual Report
2007 Annual Report
  
Stock Quote
MASI (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Price$58.64
Change (%) Stock is Up 0.33 (0.57%)
Volume308,688
Data as of 08/23/16 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Online Investor Kit
Masimo Reports Second Quarter 2016 Financial Results
2015 Form 10K
2016 Proxy Statement
2014 Annual Report
Corporate Profile
We are a global medical technology company that develops, manufactures, and markets a variety of noninvasive monitoring technologies. Our mission is to improve patient outcomes and reduce the cost of care by taking noninvasive monitoring to new sites and applications. We were incorporated in California in May 1989 and reincorporated in Delaware in May 1996.

Our core business is measure through motion and low perfusion arterial blood oxygen saturation and pulse rate monitoring, kno... 
More >>
Upcoming EventsMore >>
There are currently no events scheduled.
Recent News
RSS Feeds RSS
| More >>
Masimo Announces CE Marking for RAS-45 Sensor for rainbow Acoustic Monitoring® of Respiration Rate - 08/18/16
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Aug. 18, 2016-- Masimo (NASDAQ: MASI) announced today the CE Marking of RAS-45, a single-use adult and pediatric acoustic respiration sensor for rainbow Acoustic Monitoring® (RAM™) ... More >>
New Article Showcases an Effective Surveillance System for General Care Units Using Masimo Patient SafetyNet™ - 08/15/16
IRVINE, Calif.--(BUSINESS WIRE)--Aug. 15, 2016-- Masimo (NASDAQ:MASI) announced today that a new article published in The Joint Commission Journal on Quality and Patient Safety reports on the results of an expansion of the... More >>
Masimo Announces CE Marking for Pediatric O3™ Regional Oximetry - 08/04/16
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Aug. 4, 2016-- Masimo (NASDAQ: MASI) announced today the CE marking for the pediatric indication for O3™ regional oximetry with the O3 pediatric sensor. Regional oximetry, also refe... More >>
Masimo Reports Second Quarter 2016 Financial Results - 08/03/16
Q2 2016 Highlights (compared to Q2 2015): Total revenue, including royalties, rose 10.9% to $172.6 million Product revenue rose 11.5% to $164.6 million Masimo rainbow® revenue... More >>
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Masimo Corporation posts new information to the site. Just enter your e-mail address and click Submit.
 

To request a copy of the Annual Report, click here.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.